Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator. [electronic resource]
Producer: 20200916ISSN:- 1999-4915
- Animals
- Antiviral Agents -- pharmacology
- Cell Line
- Cells, Cultured
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Erythromycin Estolate -- pharmacology
- Female
- Humans
- Infectious Disease Transmission, Vertical -- prevention & control
- Life Cycle Stages -- drug effects
- Mice
- Pregnancy
- Viral Tropism
- Virus Internalization -- drug effects
- Zika Virus -- drug effects
- Zika Virus Infection -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.